Significance
In human patients, mutations in the LARGE gene cause congenital muscular dystrophy (CMD) type 1D, which, unlike other types of CMD, is accompanied by severe intellectual disability. Neurological phenotypes of LARGE knockout mice also suggest the possibility of impaired learning and memory. Our study using region-specific LARGE knockdown provides strong evidence that a deficit of LARGE in the hippocampus results in excitatory synapses being abnormally potentiated through the overloading of AMPA-type glutamate receptor, thereby impairing hippocampus-dependent memory. Our data reveal an intriguing role for LARGE in regulating the fine-tuning of synaptic strength in the hippocampus, which influences hippocampus-dependent memory. The results provide crucial insights for the therapeutic treatment of brain disorders associated with intellectual disability.
Keywords: intellectual disability, synaptic plasticity, AMPA receptor, LARGE
Abstract
Mutations in the human LARGE gene result in severe intellectual disability and muscular dystrophy. How LARGE mutation leads to intellectual disability, however, is unclear. In our proteomic study, LARGE was found to be a component of the AMPA-type glutamate receptor (AMPA-R) protein complex, a main player for learning and memory in the brain. Here, our functional study of LARGE showed that LARGE at the Golgi apparatus (Golgi) negatively controlled AMPA-R trafficking from the Golgi to the plasma membrane, leading to down-regulated surface and synaptic AMPA-R targeting. In LARGE knockdown mice, long-term potentiation (LTP) was occluded by synaptic AMPA-R overloading, resulting in impaired contextual fear memory. These findings indicate that the fine-tuning of AMPA-R trafficking by LARGE at the Golgi is critical for hippocampus-dependent memory in the brain. Our study thus provides insights into the pathophysiology underlying cognitive deficits in brain disorders associated with intellectual disability.
LARGE gene is expressed strongly in the brain (particularly the hippocampus) relative to other tissues (1). In humans, mutations in LARGE are associated with congenital muscular dystrophy type 1D, which is characterized by clinical features that include profound intellectual disability, abnormal electroretinogram findings, and subtle structural brain abnormalities (2–5). Largemyd mice, which carry a natural truncation mutation of LARGE, exhibit a number of neurological phenotypes, including sensorineural deafness and defective retinal transmission, along with developmental brain abnormalities (6, 7) and impaired long-term potentiation (LTP) (8). These human and mouse studies suggest that abnormal synaptic function may be responsible for intellectual disabilities in human patients with LARGE mutations.
In our previous proteomic analysis, we found that LARGE forms a protein complex with the AMPA-type glutamate receptor (AMPA-R) (9). Excitatory glutamatergic synaptic transmission within the central nervous system is primarily mediated by AMPA-R, as well as NMDA-type glutamate receptor (NMDA-R), and increasing numbers of proteins have been found to form complexes with, and thus regulate, the dynamic trafficking of AMPA-R. This tight regulation of AMPA-R trafficking in and out of the synapses, mediated by AMPA-R interactors, is widely considered to be a central brain mechanism involved in information storage (10).
In the present study, LARGE down-regulated the synaptic targeting of AMPA-R by negatively modulating AMPA-R trafficking from the Golgi apparatus (Golgi) to the cell surface. Synaptic AMPA-R overloading due to LARGE deficiency causes hippocampal LTP occlusion. Both knockout (KO; Largemyd−/−) and knockdown (KD) animals stereotaxically injected with a virus carrying small hairpin RNA (shRNA) targeting LARGE exhibited deficits in associative fear memory. Taken together, LARGE plays a critical role in memory by tuning the synaptic targeting of AMPA-R in the hippocampus. Our findings thus suggest that the abnormal trafficking of AMPA-R underlies cognitive deficits observed in patients with LARGE gene mutations.
Results
LARGE Up-Regulates the Golgi Localization of AMPA-R.
LARGE is known to localize at the Golgi in heterologous cells (11) and to function at the Golgi in myocytes (12). Similarly, in cultured hippocampal neurons, we observed a major pool of LARGE at the Golgi and Golgi outposts (Fig. 1A). Next, we analyzed the colocalization of GluA1, a subunit of AMPA-R, with the Golgi marker GM130 in cultured hippocampal neurons after manipulating LARGE expression using LARGE shRNA or LARGE rescue cDNA. The efficacy of shRNA-mediated LARGE KD and rescue was validated (SI Appendix, Fig. S1). Confocal imaging demonstrated that LARGE KD significantly decreased the pool of GluA1 at the Golgi, whereas LARGE rescue reversed this phenomenon (Fig. 1B). Similarly, in HEK293T cells, LARGE overexpression significantly increased AMPA-R localization at the Golgi (SI Appendix, Fig. S2A).
We also biochemically analyzed the effects of LARGE coexpression on subcellular AMPA-R localization by fractionating subcellular organelles from HEK293T cells transfected with GluA1 without (−LRG) or with (+LRG) LARGE (Fig. 1C). Without LARGE coexpression, the major GluA1 pool was detected in fractions enriched for P-cadherin, a plasma membrane marker. With LARGE coexpression, however, the major GluA1 pool shifted to high-density fractions enriched for GM130, a Golgi marker. Furthermore, the distributions of GluA1 and LARGE in the gradient almost completely overlapped when the proteins were coexpressed (Fig. 1C), indicating a strong and direct association. Moreover, the relative AMPA-R pool size in the Golgi fractions decreased significantly in the brains of LARGE KO mice relative to wild-type mice, whereas the relative pool size in the plasma membrane fractions increased significantly (Fig. 1D and SI Appendix, Fig. S2B). These results suggest that LARGE plays an important role in maintaining AMPA-R pools at the Golgi.
LARGE Associates with AMPA-R Through Direct Interaction.
HEK293T cells do not express synaptic proteins. Therefore, the cosedimentation and colocalization of GluA1 with LARGE in these cells (Fig. 1B and SI Appendix, Fig. S2A) suggested a direct interaction. To test this possibility, we performed reciprocal coimmunoprecipitation (co-IP) of LARGE and AMPA-R from HEK293T cells. Both co-IP strategies consistently showed that LARGE could specifically bind to AMPA-R in nonneuronal cells that do not express other known AMPA-R–binding proteins (Fig. 1E). Interestingly, in co-IP of LARGE with GluA2, LARGE binding only to the GluA2 corresponded to intracellular GluA2 (13) (SI Appendix, Fig. S3A), suggesting that LARGE binds with AMPA-R within the cell, likely at the Golgi.
We further reconstituted the interaction of LARGE with AMPA-R in vitro using an ELISA (Fig. 1 F and G). Given the molecular structures and topologies of LARGE and GluA1, we hypothesized that the C-terminal ectodomain of LARGE would bind the N-terminal ectodomain of GluA1. After confirming the purification of each protein (SI Appendix, Fig. S3 B–E), we constructed an ELISA to verify the specific and direct interaction of LARGE with GluA1 (Fig. 1 F and G). Notably, GluA1 bound to LARGE with a higher affinity relative to that exhibited by GluA2 or GluA4 (Fig. 1G).
As GluA1 binds directly to the LARGE ectodomain (including catalytic domains), we evaluated whether the interaction of LARGE with AMPA-R could affect glycosylation of the latter. However, we observed no dramatic changes in LARGE-mediated GluA1 glycosylation (SI Appendix, Fig. S4), suggesting that the physical interaction of LARGE with GluA1, rather than LARGE glycosyltransferase activity, is the essential element with respect to AMPA-R. Similarly, a previous report found that the physical interaction of Notch with OFUT1, a glycosyltransferase, rather than OFUT1 enzymatic activity, was essential to the role of OFUT1 in Notch trafficking (14).
LARGE Down-Regulates AMPA-R Surface Localization.
Our results (Fig. 1 and SI Appendix, Figs. S2 and S3) consistently demonstrate the ability of LARGE to interact directly and specifically with AMPA-R to increase localization of the latter protein at the Golgi, which suggests that LARGE could down-regulate the cell-surface localization of AMPA-R. Indeed, our surface biotinylation approach demonstrated significant increases and decreases in AMPA-R surface localization in response to LARGE KD and rescue, respectively, whereas KD or rescue did not affect total AMPA-R expression or NMDA-R surface localization (Fig. 2A). We additionally evaluated AMPA-R surface localization ex vivo using membrane-impermeable bis(sulfosuccinimidyl) suberate, which cross-links proteins exposed on the cell surface (Fig. 2B). The molecular mass of cross-linked surface GluA1 (>250 kDa) was higher than that of intracellular GluA1 (∼105 kDa), consistent with our previous study (15). Although the surface and intracellular GluA1 levels, respectively, increased and decreased significantly in Largemyd−/− mice relative to wild-type mice, NMDA-R surface localization was not affected by LARGE deficiency (Fig. 2B), further confirming that LARGE specifically modulates AMPA-R. The increased AMPA-R surface localization following LARGE KD was also confirmed at the single-cell level (Fig. 2C).
We further investigated whether LARGE could modulate AMPA-R surface localization in a heterologous expression system. Here, in HEK293T cell culture, LARGE overexpression led to strong decreases in surface GluA1 and GluA2 localization but did not affect total AMPA-R expression (Fig. 2D). The observed greater decrease in GluA1 relative to GluA2 (Fig. 2D) may be explained by the lower binding of LARGE with GluA2 compared with that with GluA1 in the ELISA (Fig. 1G). Again, the effect of LARGE overexpression on AMPA-R surface localization was recapitulated in individual hippocampal neurons (Fig. 2E).
LARGE KD Impairs Hippocampal LTP due to Postsynaptic AMPA-R Overload.
The regulation of AMPA-R trafficking by LARGE suggests a potential role of this protein in synaptic plasticity, which has been proposed by previous studies of LARGE (1–8), including LTP analysis (8). The LTP deficit in LARGE KO mice could be due to abnormal brain development, such as a neuronal migration defect (6, 8). To determine whether LARGE could affect synaptic plasticity in the normally developed adult mouse brain, we investigated hippocampal synaptic plasticity via in vivo LTP after KD of LARGE after the stereotaxic injection of an adeno-associated virus (AAV) expressing LARGE shRNA with GFP. A theta-patterned stimulation protocol readily induced long-lasting hippocampal CA1 LTP in control mice, but not in LARGE KD mice (Fig. 3A). Despite this LTP impairment, LARGE KD exhibited dramatic increases in field excitatory postsynaptic potential (fEPSP) amplitudes (Fig. 3A), leading us to analyze these amplitudes at different stimulation intensities. In an input-output analysis, the AMPA-R fEPSP amplitudes in LARGE KD mice increased significantly over input intensities of 30–100 mV (SI Appendix, Fig. S5A), However, LARGE KD did not affect presynaptic neurotransmitter release and short-term plasticity (STP), which were evaluated using the paired-pulse ratio (PPR). The PPRs at interpulse intervals of 200, 100, 75, 50, and 25 ms did not differ between control and LARGE KD mice (SI Appendix, Fig. S5B), suggesting that the synaptic changes observed in the latter mice are not presynaptic events.
The above results strongly suggest that LARGE KD increases the synaptic current by increasing the number of AMPA-R molecules at the postsynapses. Indeed, our analysis of miniature excitatory postsynaptic currents (mEPSCs) demonstrated that LARGE KD significantly increased the amplitude, but not the frequency, of mEPSCs relative to the controls (Fig. 3B). However, when we tested the effect of LARGE KD on inhibitory synapses, we observed no change in the miniature inhibitory postsynaptic current in either LARGE KD or rescue cells (SI Appendix, Fig. S6), consistent with the findings of a previous study (16). These electrophysiological analyses therefore demonstrate that changes in LARGE expression specifically affect the number of synaptic AMPA-R molecules at the excitatory postsynapses, without affecting presynapses or inhibitory synapses.
Next, we subjected cultured hippocampal neurons to confocal imaging to demonstrate that the number of GluA1 molecules within the dendritic spine increased significantly with LARGE KD relative to control neurons, and this increase was reversed by LARGE rescue (Fig. 3C). Finally, our biochemical analysis demonstrated that GluA1 expression in the postsynaptic density increased significantly in the hippocampi of LARGE KO mice relative to controls (SI Appendix, Fig. S7).
Together, the impaired hippocampal LTP (Fig. 3A) observed with LARGE KD is probably attributable to postsynaptic AMPA-R overload (Fig. 3 B and C and SI Appendix, Fig. S7), which inhibits the further capacity to increase the synaptic AMPA-R pool during LTP. Altogether, our results from those imaging, biochemistry, and electrophysiology experiments (Figs. 1–3) strongly support our working model, wherein LARGE negatively regulates AMPA-R trafficking from the Golgi to the plasma membrane, thus down-regulating AMPA-R synaptic targeting (Fig. 3D).
LARGE Deficiency Impairs Fear Memory.
The effects of LARGE KD on AMPA-R trafficking and synaptic plasticity (LTP), which underlie learning and memory in the brain, strongly suggested a role for LARGE in cognitive functions in the brain. To determine whether LARGE deficiency could cause learning and memory problems in animals, we subjected LARGE KO (Largemyd−/−), wild-type, and heterozygous mice (Largemyd+/+ and +/−) to Pavlovian fear conditioning (Fig. 4A) and observed similar freezing behaviors in all three groups (Fig. 4B). One day after fear conditioning, the mice were subjected to tests of contextual memory, an index of associative memory dependent on both hippocampal and amygdala function, and cued memory, a hippocampus-independent index of associative memory that still relies on proper amygdala function (17). Compared with wild-type mice, KO mice displayed significant reductions in freezing behavior during both contextual and cued memory tests (Fig. 4 C and D), indicating that LARGE KO leads to deficits in both hippocampus- and amygdala-dependent memory.
We note, however, that KO mice are constitutive mutants. Therefore, the observed memory deficits may be attributable to abnormal brain development. Accordingly, we knocked down LARGE in the bilateral hippocampal CA1 regions of adult mice and rats via the stereotaxic injection of an AAV expressing LARGE shRNA with GFP before Pavlovian fear conditioning to examine the potential effects of LARGE on memory processes in the absence of life-long inherent developmental abnormalities. Another group of mice injected with AAV expressing scrambled shRNA with GFP served as a control. We subsequently validated the efficacy of shRNA-mediated LARGE KD in vivo (SI Appendix, Fig. S8) and confirmed the reliability of the experimental animals used in fear tests (SI Appendix, Fig. S9). Although the two groups exhibited similar freezing behavior (Fig. 4E), LARGE KD mice exhibited significantly less freezing behavior during contextual but not cued memory tests (Fig. 4 F and G). In rats, LARGE KD in the hippocampal CA1 produced the same effects on memory (Fig. 4 H–J).
Discussion
Here, using a multidisciplinary approach, we obtained several lines of evidence that consistently and strongly support our hypothesis that LARGE down-regulates the cell-surface localization, and thus synaptic targeting, of AMPA-R by modulating AMPA-R trafficking from the Golgi to the plasma membrane. Moreover, increasing synaptic AMPA-R by knocking down LARGE occluded hippocampal LTP in vivo, resulting in a significant deficit in associative memory. Therefore, LARGE regulation of AMPA-R trafficking ultimately regulates memory. Given that LARGE mutations are linked to intellectual disabilities, this regulation of AMPA-R trafficking, as well as memory by LARGE, provides insight into the pathophysiology of neurological and psychiatric disorders associated with intellectual disability.
Our previous mass spectrometry and Western blot analyses suggested a specific interaction of LARGE with AMPA-R in the brain (9). Our protein–protein interaction assays using HEK293T cells and ELISA (Fig. 1 E–G) confirmed the specific and direct interaction between the two proteins. HEK293T cells do not express synaptic proteins that might serve as intermediaries in the interaction of LARGE and AMPA-R. The ELISA was performed with purified proteins in vitro, which demonstrated that N-terminal ectodomain of AMPA-R binds to C-terminal ectodomain of LARGE. including two catalytic domains (CD1 and CD2) (Fig. 1 F and G). We could not narrow down the AMPA-R–binding domain of LARGE further since the truncation mutants of LARGE exhibit a totally different subcellular localization in HEK293T cells compared with wild-type LARGE (11). Since the protein purification yield of the CD1 or CD2 domain of LARGE was too low, probably due to low stability of the truncated proteins, the domains could not be used for the ELISA.
Although impaired LTP in hippocampal slices of Largemyd−/− mice has been previously reported (8), this LTP occlusion is likely attributable to developmental defects in the hippocampus that result in abnormal neuronal migration, as reported by the same group (7, 18). In contrast, our study demonstrated the outcome of a LARGE deficit in adult animals, showing that memory deficits (Fig. 4 E–J), as well as occluded LTP (Fig. 3A), follow LARGE KD in the hippocampus. While the impaired LTP induction and deficits in memory make intuitive sense, the occlusion of LTP by increased surface and synaptic targeting of AMPA-R might seem paradoxical. However, consistent with our results, LTP occlusion due to elevation in postsynaptic AMPA-R surface localization and function was reported previously (19). Previous studies also have shown that abnormally increased synaptic activity impairs LTP and memory. For example, enhanced synaptic responses suppress LTP development, resulting in hippocampal memory deficits (20), whereas chronically increased fEPSPs cause persistent deficits in the acquisition of new spatial information (21, 22). Our electrophysiological (Fig. 3B), imaging (Fig. 3C), and biochemical (SI Appendix, Fig. S7) experiments consistently demonstrated that the number of synaptic AMPA-Rs is significantly increased by LARGE KD. Taken together, our results suggest that the overloading of synaptic AMPA-R caused by LARGE KD blocks further synaptic targeting of AMPA-R, resulting in occlusion of LTP. Therefore, consistent with previous studies, our study demonstrates that an appropriate balance between supply and removal of AMPA-R at synapses is necessary for normal LTP induction.
Our input-output analysis, in which the AMPA-R fEPSP amplitudes in LARGE KD mice increased significantly over all input intensities (SI Appendix, Fig. S5A), suggests a potentiated postsynaptic response by LARGE KD, leading to our hypothesis that LARGE KD increases the synaptic current by increasing the number of AMPA-R molecules at the postsynapses. On the other hand, the input-output change could be due to increased excitability of postsynaptic dendrites, as a result of a decreased threshold for action potential generation by alteration of dendritic ion channels. This phenomenon is known as EPSP-spike potentiation (23, 24). Thus, it is possible that LARGE may affect trafficking of ion channels involved in action potential generation.
In contrast to LTP induction, which was abrogated by LARGE KD, STP remained intact in LARGE KD mice (SI Appendix, Fig. S5B), a result consistent with the normal acquisition of fear training in LARGE KO and LARGE KD animals (Fig. 4 B, E, and H). The fact that the STP was not changed by LARGE KD also supports our hypothesis that the effect of LARGE on synaptic plasticity is postsynaptic rather than presynaptic, as demonstrated by the absence of an effect of LARGE KD or overexpression on mEPSC frequency (Fig. 3B).
LARGE2 (GYLTL1B) is a homolog of LARGE (11) that, in principle, could compensate for the loss of LARGE (25). However, LARGE2 is not expressed in the brain (25), and is thus unlikely to compensate for the loss of LARGE in neuronal cultures or the brain. Our functional studies of LARGE also consistently suggest that the loss of LARGE in neurons is not compensated for by a homolog in the brain, at least in terms of LARGE function in AMPA-R trafficking and memory.
LARGE function in the brain has been studied by focusing on its association with the dystrophin glycoprotein complex (DGC) (7, 8, 16). However, the DGC, including dystroglycan, is specifically expressed in inhibitory GABAergic synapses and is not detected at excitatory glutamatergic synapses (16, 26). LARGE KD has no effect on inhibitory synaptic current (SI Appendix, Fig. S5), which is consistent with the findings of a previous study (16). In contrast, our study is focused on the function of LARGE in excitatory synapses where AMPA-Rs are expressed, which provided insight into the intellectual disability associated with LARGE mutations in patients with muscular dystrophy.
Intellectual disability refers to what used to be called “mental retardation,” which is characterized by significant limitations in both intellectual functioning (intelligence quotient < 70) and adaptive behavior, as expressed in conceptual, social, and practical skills before the age of 18 y (27), and other cognitive deficits that are acquired throughout the lifespan (e.g., neurodegenerative-based dementia). Many X-linked brain disorders associated with intellectual disability are related to the proteins involved in the signaling pathways that support synaptic function (4). Fragile X syndrome, the most common form of inherited intellectual disability, is directly linked to the dysregulation of AMPA-R (28). Moreover, the intellectual disability-associated proteins PAK3 (p21 protein-activated kinase 3) and OPHN1 (oligophrenin 1) regulate the expression and stability of synaptic AMPA-R, respectively (29, 30). Furthermore, mutations in the GluA3 subunit of AMPA-R have been found in patients with X-linked intellectual disability (31). The nature of the alterations in AMPA-R trafficking and the manner in which these changes contribute to intellectual disability, however, remain largely unknown. In this regard, the regulation of AMPA-R trafficking and memory by the intellectual disability-associated protein LARGE demonstrated in this study provides useful clues for elucidating the pathophysiology underlying cognitive deficits in neurological and psychiatric disorders associated with intellectual disability.
Materials and Methods
Detailed experimental methods are described in SI Appendix. The use and care of animals in this study were performed in accordance with procedures approved by the Institutional Animal Care and Use Committee at the University of Texas Medical Branch and the Korea Advanced Institute of Science and Technology.
Preparation of cDNA, shRNA, and Viruses.
LARGE expression vectors were kindly provided by Kevin Campbell, University of Iowa, Iowa City, IA. AAV constructs were designed, generated, and screened as previously described (details are provided in SI Appendix).
Animal Behavior Tests.
Fear conditioning and fear memory tests were performed as described in SI Appendix.
Electrophysiological Analyses.
Whole-cell voltage-clamping recordings of mEPSCs and in vivo fEPSP recordings were recorded as previously described (details are provided in SI Appendix).
Supplementary Material
Acknowledgments
We thank Drs. Kevin P. Campbell and Richard L. Huganir for the generous gifts of cDNA plasmids, antibodies, and Largemyd mice. We thank all of the M.-G.K. laboratory members for technical assistance and advice in this study. This work was supported by the Institute for Basic Science (Grant R001-D1) and the University of Texas Medical Branch.
Footnotes
The authors declare no conflict of interest.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1805060115/-/DCSupplemental.
References
- 1.Peyrard M, et al. The human LARGE gene from 22q12.3-q13.1 is a new, distinct member of the glycosyltransferase gene family. Proc Natl Acad Sci USA. 1999;96:598–603. doi: 10.1073/pnas.96.2.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Clarke NF, et al. Congenital muscular dystrophy type 1D (MDC1D) due to a large intragenic insertion/deletion, involving intron 10 of the LARGE gene. Eur J Hum Genet. 2011;19:452–457. doi: 10.1038/ejhg.2010.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Longman C, et al. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum Mol Genet. 2003;12:2853–2861. doi: 10.1093/hmg/ddg307. [DOI] [PubMed] [Google Scholar]
- 4.Vaillend C, Poirier R, Laroche S. Genes, plasticity and mental retardation. Behav Brain Res. 2008;192:88–105. doi: 10.1016/j.bbr.2008.01.009. [DOI] [PubMed] [Google Scholar]
- 5.Lisi MT, Cohn RD. Congenital muscular dystrophies: New aspects of an expanding group of disorders. Biochim Biophys Acta. 2007;1772:159–172. doi: 10.1016/j.bbadis.2006.09.006. [DOI] [PubMed] [Google Scholar]
- 6.Holzfeind PJ, et al. Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Large(myd) mouse defines a natural model for glycosylation-deficient muscle - eye - brain disorders. Hum Mol Genet. 2002;11:2673–2687. doi: 10.1093/hmg/11.21.2673. [DOI] [PubMed] [Google Scholar]
- 7.Michele DE, et al. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature. 2002;418:417–422. doi: 10.1038/nature00837. [DOI] [PubMed] [Google Scholar]
- 8.Satz JS, et al. Distinct functions of glial and neuronal dystroglycan in the developing and adult mouse brain. J Neurosci. 2010;30:14560–14572. doi: 10.1523/JNEUROSCI.3247-10.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kang MG, et al. Proteomic analysis of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor complexes. J Biol Chem. 2012;287:28632–28645. doi: 10.1074/jbc.M111.336644. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Henley JM, Barker EA, Glebov OO. Routes, destinations and delays: Recent advances in AMPA receptor trafficking. Trends Neurosci. 2011;34:258–268. doi: 10.1016/j.tins.2011.02.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Brockington M, et al. Localization and functional analysis of the LARGE family of glycosyltransferases: Significance for muscular dystrophy. Hum Mol Genet. 2005;14:657–665. doi: 10.1093/hmg/ddi062. [DOI] [PubMed] [Google Scholar]
- 12.Kanagawa M, et al. Molecular recognition by LARGE is essential for expression of functional dystroglycan. Cell. 2004;117:953–964. doi: 10.1016/j.cell.2004.06.003. [DOI] [PubMed] [Google Scholar]
- 13.Hall RA, Hansen A, Andersen PH, Soderling TR. Surface expression of the AMPA receptor subunits GluR1, GluR2, and GluR4 in stably transfected baby hamster kidney cells. J Neurochem. 1997;68:625–630. doi: 10.1046/j.1471-4159.1997.68020625.x. [DOI] [PubMed] [Google Scholar]
- 14.Okajima T, Xu A, Lei L, Irvine KD. Chaperone activity of protein O-fucosyltransferase 1 promotes notch receptor folding. Science. 2005;307:1599–1603. doi: 10.1126/science.1108995. [DOI] [PubMed] [Google Scholar]
- 15.Lee DZ, Chung JM, Chung K, Kang MG. Reactive oxygen species (ROS) modulate AMPA receptor phosphorylation and cell-surface localization in concert with pain-related behavior. Pain. 2012;153:1905–1915. doi: 10.1016/j.pain.2012.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Pribiag H, Peng H, Shah WA, Stellwagen D, Carbonetto S. Dystroglycan mediates homeostatic synaptic plasticity at GABAergic synapses. Proc Natl Acad Sci USA. 2014;111:6810–6815. doi: 10.1073/pnas.1321774111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Sanders MJ, Wiltgen BJ, Fanselow MS. The place of the hippocampus in fear conditioning. Eur J Pharmacol. 2003;463:217–223. doi: 10.1016/s0014-2999(03)01283-4. [DOI] [PubMed] [Google Scholar]
- 18.Michele DE, Campbell KP. Dystrophin-glycoprotein complex: Post-translational process6ing and dystroglycan function. J Biol Chem. 2003;278:15457–15460. doi: 10.1074/jbc.R200031200. [DOI] [PubMed] [Google Scholar]
- 19.Traunmüller L, Gomez AM, Nguyen TM, Scheiffele P. Control of neuronal synapse specification by a highly dedicated alternative splicing program. Science. 2016;352:982–986. doi: 10.1126/science.aaf2397. [DOI] [PubMed] [Google Scholar]
- 20.Barnes CA, et al. LTP saturation and spatial learning disruption: Effects of task variables and saturation levels. J Neurosci. 1994;14:5793–5806. doi: 10.1523/JNEUROSCI.14-10-05793.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Castro CA, Silbert LH, McNaughton BL, Barnes CA. Recovery of spatial learning deficits after decay of electrically induced synaptic enhancement in the hippocampus. Nature. 1989;342:545–548. doi: 10.1038/342545a0. [DOI] [PubMed] [Google Scholar]
- 22.McNaughton BL, Barnes CA, Rao G, Baldwin J, Rasmussen M. Long-term enhancement of hippocampal synaptic transmission and the acquisition of spatial information. J Neurosci. 1986;6:563–571. doi: 10.1523/JNEUROSCI.06-02-00563.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Bliss TV, Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol. 1973;232:331–356. doi: 10.1113/jphysiol.1973.sp010273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Staff NP, Spruston N. Intracellular correlate of EPSP-spike potentiation in CA1 pyramidal neurons is controlled by GABAergic modulation. Hippocampus. 2003;13:801–805. doi: 10.1002/hipo.10129. [DOI] [PubMed] [Google Scholar]
- 25.Fujimura K, et al. LARGE2 facilitates the maturation of alpha-dystroglycan more effectively than LARGE. Biochem Biophys Res Commun. 2005;329:1162–1171. doi: 10.1016/j.bbrc.2005.02.082. [DOI] [PubMed] [Google Scholar]
- 26.Lévi S, et al. Dystroglycan is selectively associated with inhibitory GABAergic synapses but is dispensable for their differentiation. J Neurosci. 2002;22:4274–4285. doi: 10.1523/JNEUROSCI.22-11-04274.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Kaufman L, Ayub M, Vincent JB. The genetic basis of non-syndromic intellectual disability: A review. J Neurodev Disord. 2010;2:182–209. doi: 10.1007/s11689-010-9055-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Bowie D. Ionotropic glutamate receptors & CNS disorders. CNS Neurol Disord Drug Targets. 2008;7:129–143. doi: 10.2174/187152708784083821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Boda B, et al. The mental retardation protein PAK3 contributes to synapse formation and plasticity in hippocampus. J Neurosci. 2004;24:10816–10825. doi: 10.1523/JNEUROSCI.2931-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Nadif Kasri N, Nakano-Kobayashi A, Malinow R, Li B, Van Aelst L. The Rho-linked mental retardation protein oligophrenin-1 controls synapse maturation and plasticity by stabilizing AMPA receptors. Genes Dev. 2009;23:1289–1302. doi: 10.1101/gad.1783809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Wu Y, et al. Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated with moderate cognitive impairment in humans. Proc Natl Acad Sci USA. 2007;104:18163–18168. doi: 10.1073/pnas.0708699104. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.